Teva Branded Pharmaceutical Products R&d Llc

This study tests an injectable drug called TEV-53408 in 50 adults with celiac disease who follow a gluten-free diet. Participants will be exposed to small amounts of gluten to see if the drug can prevent intestinal damage. The trial is placebo-controlled and lasts about 86 weeks,…

This study tests two different doses of TEV-48574 (duvakitug) given as a shot every 4 weeks to adults with moderate to severe ulcerative colitis or Crohn's disease. Participants who completed a previous 14-week study can join. The goal is to see if the drug can keep the disease u…

This early-stage trial tests a new drug called TEV-53408 in 38 adults with vitiligo, a condition that causes white patches on the skin. The main goal is to see if the drug is safe and to check for side effects. Participants receive the drug as a shot for 24 weeks, then are monito…

This study tests whether a new inhaler that combines two medicines (fluticasone and albuterol) can prevent severe asthma attacks better than albuterol alone. About 2,772 adults with asthma who have had at least one severe attack in the past year will take part. The study lasts at…

This study aimed to test a new drug called TAK-573, given with steroids and other cancer drugs, for people with multiple myeloma that came back or didn't respond to treatment. The goal was to find a safe dose and see if it helps shrink tumors. However, the trial was withdrawn bef…